Page last updated: 2024-08-26

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Hepatorenal Syndrome

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Hepatorenal Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, K; Fukuda, H; Kawamoto, M; Yuge, O1

Trials

1 trial(s) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Hepatorenal Syndrome

ArticleYear
A comparison of the effects of prolonged (>10 hour) low-flow sevoflurane, high-flow sevoflurane, and low-flow isoflurane anaesthesia on hepatorenal function in orthopaedic patients.
    Anaesthesia and intensive care, 2004, Volume: 32, Issue:2

    Topics: Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Biomarkers; Chromatography, Gas; Ethers; Female; Hepatorenal Syndrome; Humans; Hydrocarbons, Fluorinated; Isoflurane; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Male; Methyl Ethers; Sevoflurane; Surgical Flaps; Time Factors

2004